慢性病中的脆弱性评估工具:系统性审查和元分析
Alisha Puri1, Anita M Lloyd2, Aminu K Bello2
1Meharry Medical College, Nashville, TN.
Kidney medicine
|February 21, 2025
概括
在慢性病 (CKD) 中,虚弱是常见的. 脆性表型和临床脆弱性尺度有效预测CKD患者的死亡率和住院.
科学领域:
- 老年学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物统计学 生物统计学
背景情况:
- 虚弱,生理储备的下降,在慢性病 (CKD) 中普遍存在,并与不良结果有关.
- 在CKD中评估脆弱性评估工具对于患者的管理和预后至关重要.
研究的目的:
- 为了评估成年人患有CKD的脆弱工具的测量特性.
- 总结CKD人群中脆弱性和死亡率或住院治疗之间的关联.
主要方法:
- 105项研究的系统审查和元分析.
- 包括观察性研究和随机试验,评估CKD中的多维脆弱性工具.
- 数据使用随机效应模型进行聚合或以叙事方式合成.
主要成果:
- 碎的脆弱性表型 (FFP) 和临床脆弱性量表显示了可接受的死亡率和住院治疗的歧视性有效性.
- 疲劳,抵抗,行走,疾病和体重减轻等级表现出对非透析性慢性瘤的死亡率的一致的歧视性有效性.
- 临床医生的主观脆弱性评估和验证的工具之间的一致性很低.
结论:
- FFP和临床脆弱度表是预测CKD临床结果的有效工具.
- 当直接测量不切实际时,修改后的FFP提供了一个可行的替代方案.
- 临床医生的主观脆弱性评估对于识别CKD患者的脆弱性是不可靠的.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...


